Blueshift Asset Management, LLC Thermo Fisher Scientific Inc. Transaction History

Blueshift Asset Management, LLC

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	BUY	$431.41 - $532.94 $590,168 - $729,061	1,368 New	1,368 $726,000
Q2 2023 Aug 15, 2023	BUY	$508.46 - $591.13 $576,085 - $669,750	1,133 New	1,133 $591,000
Q4 2022 Feb 14, 2023	BUY	$484.71 - $571.37 $190,975 - $225,119	394 Added 51.57%	1,158 $637,000
Q3 2022 Nov 14, 2022	BUY	$507.19 - $604.49 $387,493 - $461,830	764 New	764 $387,000
Q2 2022 Aug 12, 2022	SELL	$500.9 - $612.21 $241,934 - $295,697	-483 Closed	0 $0
Q1 2022 May 12, 2022	SELL	$524.0 - $644.92 $3.17 Million - $3.9 Million	-6,051 Reduced 92.61%	483 $285,000
Q4 2021 Feb 11, 2022	BUY	$569.0 - $667.24 $2.96 Million - $3.47 Million	5,202 Added 390.54%	6,534 $4.36 Million
Q3 2021 Nov 12, 2021	SELL	$509.53 - $609.78 $4.94 Million - $5.91 Million	-9,691 Reduced 87.92%	1,332 $761,000
Q2 2021 Aug 13, 2021	BUY	$441.0 - $508.24 $362,943 - $418,281	823 Added 8.07%	11,023 $5.56 Million
Q1 2021 May 06, 2021	BUY	$439.85 - $518.83 $3.54 Million - $4.18 Million	8,059 Added 376.41%	10,200 $4.66 Million
Q4 2020 Feb 12, 2021	BUY	$435.06 - $527.66 $931,463 - $1.13 Million	2,141 New	2,141 $997,000
Q3 2020 Nov 13, 2020	SELL	$359.77 - $441.52 $1.76 Million - $2.15 Million	-4,879 Closed	0 $0
Q2 2020 Aug 13, 2020	BUY	$275.2 - $362.34 $1.34 Million - $1.77 Million	4,879 New	4,879 $1.77 Million
Q1 2020 May 14, 2020	SELL	$255.3 - $340.05 $745,476 - $992,946	-2,920 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$271.93 - $328.04 $794,035 - $957,876	2,920 New	2,920 $949,000

2,872

341M

2.16M

3.05M

Ticker TMO
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 391,788,992
Market Cap $208B
Description
Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as di...

Get notified when there are updates to the investment portfolio of Blueshift Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Blueshift Asset Management, LLC with notifications on news.